Summary: DOPA decarboxylase is the enzyme directly responsible for the synthesis of the neurotransmitters do pamine and serotonin, and indirectly of noradrenaline, in brain. We used the decarboHlation coefficient (�) of 6-esp]fluoro-DOPA (PDOPA) to denote the relative ac tivity of L-DOPA decarboxylase in vivo in the human brain. To determine the relative enzyme activity with positron emission tomography (PET), we evaluated the model that separates the metabolism into compartments of nondiffusible and diffusible (i.e., transient) tracer me tabolites. Error analysis indicated that the least-squares optimization alone was not sufficient to yield accurate estimates of � in the presence of the inherent error of PET. To improve the accuracy of the kf estimates by optimizing the number of parameters, we introduced bi ological constraints which included a tracer partition vol-
ume (Ve) common to frontal cortex and striatum, and a fixed ratio (q) between the blood-brain barrier transport coefficients of O-methyl-['sp]fluoro-DOPA and PDOPA, the two sources of radioactivity in plasma. We found that a two-step analysis yielded sufficiently accurate estimates of kf. The two steps include the initial estimation of the partition volume in frontal cortex and the subsequent use of this value to determine kf in striatum and other struc tures. We studied twelve healthy controls (age 45 ± 15 years). The average � value was 0.081 ± 0.024 min-1 (coefficient of variation (COV) 30%) for caudate nucleus, 0.074 ± 0.013 min -I (COV 18%) for putamen, and 0.010 ± 0.005 min -I (COV 50%) for cerebral cortex. Key Words: Striatum-L-DOPA decarboxylase-6-['sP]fluoro-DOPA-Positron emission tomography Error analysis.
Positron emission tomography (PET) of the brain has demonstrated distinct accumulation of radioac tivity in regions with known dopaminergic neuro transmission following the administration of 6-esP]fluoro-L-DOPA (PDOPA), an analogue of na tive L-3,4-dihydroxyphenylalanine (L-DOPA) (Gar nett et al., 1983) . Specific methods of quantification of the PDOPA accumulation have been proposed (Leenders et aI., 1986b; Martin et aI., 1986; Gjedde et aI., 1991; Brooks et aI., 1990; Hartvig et aI., 1991; Huang et aI., 1991) . They have succeeded in con firming postmortem observations of more promi nent involvement of the putamen than caudate nu cleus in Parkinson's disease (Martin et aI., 1986; Leenders et aI., 1986a) , and the clinically important information on degenerative disorders involving the nigrostriatal system (Brooks et aI., 1990; Lindvall et aI., 1990) .
The FDOPA-PET method potentially yields in formation about three distinct processes in the ce rebral dopaminergic system, i.e., the transport of FDOPA across the blood-brain barrier for large neutral amino acids (LNAA) (Oldendorf and Szabo, 1976; Wade and Katzman, 1975) , decarboxylation by DOPA decarboxylase (EC 4.1.1.28), and the tis sue's ability to retain newly formed fluorodopamine (FDA) and its major metabolites capable of leaving the brain by diffusion (Neff et aI., 1967; Gordon et aI., 1976; Grabowska-Anden et aI., 1984) . How ever, only a few attempts have been made to mea sure the activity of DOPA decarboxylase by a model consistent with the underlying physiology and biochemistry of the dopaminergic system (Gjedde et aI., 1991; Huang et aI., 1991) . In this study, we separated the compartment of FDA and its metabolites into nondiffusible (mainly FDA) and diffusible compartments. In essence, free FDOPA is the immediate substrate of the enzyme and is converted to FDA which is further metabolized to L-3 ,4-dihydroxy-6-[ 18F]fluorophenylacetic acid (FDOPAC) and eSF]6-fluoro-homovanillic acid (FHV A) which leave the brain by diffusion. Incor poration of the lag time of this escape may provide a better description of the time course of FDOPA metabolism in the brain. Thus, the primary goal of this study was to test the feasibility of the new model, and to provide normal values of the relative activity of L-DOPA decarboxylase in vivo (Gjedde et aI., 1991 In practice, we raised the possibility that least squares optimization and complex compartment analysis of PET data with intrinsic variability may yield estimates of model parameters that are far from the predictions based on known physiological and biochemical principles. The FDOPA model is susceptible to this bias because the model configu ration is complicated by the existence of radioactive metabolites of FDOPA in plasma and metabolism of FDOPA in the brain other than simple decarboxyl ation and product trapping (Fig. 1) . A potent rem edy for this bias is the use of biological constraints that guide the estimates inside their physiological bounds. Thus, it was an essential purpose of this study to identify the potential for bias in the FDOPA model and to examine valid biological con straints that may prevent the bias. We assume that the distribution of FDOPA is ho mogeneous in any brain region [precursor compart ment, M�(t)] because local diffusion and transport across cell membranes are rapid in comparison with the transfer across the blood-brain barrier. We also assume that FDA remains within the region. of ori gin for the duration of the study, while some of its major metabolites such as FDOPAC and FHV A (Wade and Katzman, 1975) . We assume that O-methylation of FDOPA (Kirk and Creveling, 1984) occurs in the brain, of course, but that OMFD is not metabolized further [OMFD compartment, MM(t) ].
The movement of substances between the com partments is given by the following set of differen tial equations, and, where C�(t) and C�(t) are radioactivity concentra tions of FDOPA and OMFD in arterial plasma at time t, respectively, K, and k 2 are the unidirectional and fractional clearances from blood to brain, and the reverse, of FDOPA or OMFD (with super scripts D and M), and kP, k?, k�, and kYj the model coefficients for the decarboxylation and O-methyl ation reactions of FDOPA, O-methylation and/or oxidation reactions of FDA in brain, and loss of metabolites from brain, in this order. High perfor mance liquid chromatography (HPLC) analysis dis closed the presence of unknown compounds in plasma with less than 5% of the total plasma activ ity. We assume that they do not cross the blood brain barrier.
Biological constraints
To increase the accuracy of the estimates of DOPA decarboxylase activity, we introduced the following biological constraints. The constraints were derived from the observation that the facili tated diffusion of large neutral amino acids, by which FDOPA and OMFD are transported into and out of brain, obeys Michaelis-Menten kinetics (Old endorf and Szabo 1976).
[a] The Michaelis-Menten kinetics yields an ex pression for the partition volume Ve, equal to the K,lk 2 ratio (Gjedde 1982).
where Vd is the relative brain water content, and Ca, Me' and Kt are the plasma concentration, brain co � ten i , and th e half-saturation constant, of the i-th amino acid competing for the transporter. Equation (5) shows that the value of Ve is the same for all substrates sharing the transport. In addition, the variability of Ve among the regions of the brain must be negligible because so many different large neu tral amino acids are transported by the LNAA transporter that the sum of the MelKt ratios can be expected to remain constant among regions.
[b] The ratio between the clearances of FDOPA and OMFD is a constant because this ratio is given by the ratios of half-saturation constants (Kt) and the maximal transport velocity (T max) of the two substances (Gjedde and Christensen, 1984) , (6) The introduction of Ve and q allowed us to elim inate k� of FDOPA, and Kr and k� of O-methyl FDOPA from the equations because k� = KPIVe, Kr = qKP , and k� = qk�.
Significance of model parameter kP
In the presence of the native substrate DOPA, the Michaelis-Menten equation relates the model pa rameter kP to the kinetic constants of the enzyme, (7) where V�ax is the maximal velocity of the decar boxylation reaction of tracer FDOPA in vivo, Km and K� the Michaelis half-saturation constants of the reaction, Me and M!;' the contents of endoge nous L-DOPA and tracer FDOPA in brain, respec tively, and V d the brain water volume. V�ax is a property of the quantity of enzyme present in a re gion of brain.
The enzyme tyrosine hydroxylase is generally be lieved to be the rate-limiting step of dopamine syn thesis in vivo (Wurtman et al., 1980) . If endoge nously synthesized L-DOPA is immediately decar boxylated to dopamine (i.e., M!;' « K�; Me « Km; see Discussion), Eq. 7 can be rewritten as, Thus, in vivo, the model parameter kfi is directly proportional to the total number of enzyme mole cules in a brain region.
If the enzyme is unregulated, the Km is likely to vary little during physiological and pathological al terations of the cerebral dopaminergic system, un like tyrosine hydroxylase. For this reason, we refer to kfi as the relative L-DOPA decarboxylase activity of a brain region.
METHODS

Error analysis
The aim of error analysis was, first, to examine wheth er the least-squares optimization procedure alone is suf ficient to yield valid estimates of interest (i.e., k?) on the basis of the extended FDOPA model, and, if insufficient, to identify a remedy. Second, we intended to examine the effects on the k? estimates of properties of the model other than DOPA decarboxylation. They included O-methylation of FDOPA in brain ("f), and the ratio be tween the unidirectional clearances of OMFD and FDOPA (q).
Simulated PET data were generated using equations (A3-AI6) (see Appendix) with arbitrary (but close to ac tual) values of individual transfer coefficients (input val ues) together with the plasma radioactivity data acquired during an actual PET study. "Noise" (statistical variabil ity) was added to the data taking the Poisson nature of the radiation events and the error characteristics of the Scan ditronix PC-2408 PET camera into account. The different magnitudes of noise were predetermined as the standard deviation of Gaussian random variables with respect to the size of regions of interest (ROI), and the counts re corded in them on the basis of phantom studies (Yasuhara et al., in preparation) .
In the error analysis of Ve and k?, all transfer coeffi cients were allowed to vary in each pixel during the gen eration of the PET data, assuming a normal distribution with coefficients of variation of 10% (±5%) for the Kf, kf, and Vo terms, and 3% (±1.5%) for the Ve term. The expected error of each estimate was expressed by the coefficient of root-mean-squared (r.m.s.) deviation from individual input values, based on 100 trials.
PET studies and data analysis
We studied 12 healthy, neurologically normal subjects (mean ages 45 ± 15 years). Permission to conduct the study was granted by the Ethics and Research Review Committee of Montreal Neurological Institute, and signed consent forms were obtained from the subjects before the study. One hundred mg Carbidopa were given to the subjects 2 h before the study with additional doses (50 mg every hour) in the event of a delay.
Subjects were scanned with the Scanditronix PC-2048 15B PET camera (Uppsala, Sweden) for 90 min following injection of �200 MBq of 18F-DOPA. A total of 27 frames were acquired during 90 min (six 30-s, seven I-min, five 2-min, four 5-min, and five 10-min scans). The PET cam era has a transverse resolution of 5.8-6.4 mm and an axial resolution of 6.1-7.1 mm full width at half-maximum J Cereb Blood Flow Metab, Vol. 13, No.1, 1993 (FWHM) (Evans et al., 1991a) . Each PET image was re constructed to a 128 x 128 matrix of 2 x 2 mm pixels (25.6 mm3 in volume), correcting for tissue attenuation, deadtime, scatter, and coincident counts. We took the midtime of a PET frame as the time of the frame and the mean activity associated with a ROI as the radioactivity of the corresponding structure. Plasma samples were taken every 10 s in the beginning, with increasingly pro longed sampling intervals later. The activity was mea sured by the cross-calibrated Canberra 802-3W well-type scintillation counter (Ramsey, NJ, U.S.A.) and corrected for the sample weights. Both tissue and plasma radioac tivity series were corrected for physical decay of [18F] to the time of injection. Ten to twelve plasma samples were analyzed with HPLC to determine the chemical nature of the radioactivity in plasma (typically at 3, 5, 7.5, 10, 12.5, 15,20,25,30, 35,45, and 60 min) . A detailed description of the HPLC procedure has been given elsewhere (Reith et al., 1990) . In six subjects, two additional samples (75 and 90 min) underwent HPLC analysis. On the basis that the time course of the FDOPAIOMFD ratio rapidly ap proached a line (Boyes et al., 1986) , we calculated the radioactivity of FDOPA and OMFD in plasma by linearly interpolating fractions at each sampling point.
Anatomical identification and manual definition of these structures were carried out using resliced magnetic resonance (MR) images, adjusted to the angulation, rota tion, and position of the PET images (Evans et al., 1991h) . We could identify the head of the caudate nucleus and putamen on at least three consecutive resliced MRI planes, and chose the middle two slices to draw the ROI. To represent the radioactivity of a structure, we used the average value of the two PET slices weighted for the area of the structure in each plane. For cortical regions, we used the weighted average of at least two PET slices for each region (the total area exceeding 16 cm2, or 10.2 cm3 in volume).
Based on the results of the simulation (see Results and Discussion), we analyzed the data in the followmg man ner. First, we estimated Ve, using the frontal cortex iden tified in four to six PET planes. Then, we estimated kf in the caudate and putamen, maintaining Ve at the frontal Ve value. To obtain normal values of the relative L-DOPA decarboxylase activity, we used data recorded during the first 60 min of study. In the fitting procedures, we used a value of 2.3 for q, determined in rats (Reith et al., 1990) .
We set the values of kr;, kIf, and lei to zero for the cortical regions, and to zero, 0.02, and 0.005 min -I , respectively, for striatum and other selected cortical regions. We also included Vo to denote the brain vascular volume, which was always included as a parameter.
RESULTS
Error analysis
Estimates without and with constraints. The mean estimates of KP, kfi, and Ve were plotted as a function of the input value of kP ( Fig. 2A) . We chose a ROI of 2.0 cm 2 area (1.25 cm 3 ) because the area of the caudate nucleus and putamen identified in the MRI planes averaged 1.1 and 3.2 cm 2 , respec tively. The estimates of kP and Ve deviated from their respective input values when the input kP was greater than 0.01 min -1. The magnitude of this de-vlatlOn increased when the input kP value in creased. The deviations of kP and kr ( = KPIVe) were correlated such that the deviation of the net clearance of FDOPA (KD = KPkP/[� + kPD from its input value was negligible (data not shown).
The percentage (%) root-mean-squared error (r.m.s. error) of the Ve estimates was plotted as functions of the size of the ROI (inversely propor tional to noise level) and the input values of kP (Fig.   2B ). We found that the larger the ROIs, and the lower the input kP, the more precise the estimates of Ve became. When "true" values of kP and Ve were 0.01 min -I and 0.8 ml g-I, we expected a 3% range of the r.m.s. error for Ve'
On the basis of the previous error analysis and the theoretical expectation of common Ve values for striatum and cortical regions (see Theory and Dis cussion), we tested the feasibility of a two-step analysis as a remedy for the systematic deviations of Fig. 2A . The analysis consisted in initial estimate of Ve with simulated PET data of a large ROI (14.4 cm 2 or 9.2 cm 3 ) and subsequent estimate of kP in a small ROI (2.0 cm 2 or 1.25 cm 3 ) with Ve fixed to the estimated value. Figure 2C shows the mean kP es timates and mean r.m.s. error as a function of the input kP. The two-step analysis eliminated the sys tematic deviation of the kP estimates. The r.m.s. error of the kP estimates was expected to be in the 10-15% range. For this reason, we decided to adopt the two-step analysis as a remedy for the insuffi ciency of the least-squares optimization under the influence of the error characteristics of our current PET observations.
Influence of q and FDOPA O-methylation. In the analysis of actual PET data, we fixed q to 2.3 and ignored the O-methylation of FDOPA in the brain (kr = 0), although neither the value of q nor the magnitude of FDOPA O-methylation in human brain has yet been determined. Figure 3A ,B demonstrates the effects on the Ve and kP estimates of fixing q to 2.3 in the fitting procedure when the "true" value was different from this value. When the "true" q was 1.8, the r.m.s. errors of the Ve estimates increased by �8% because of a systematic underestimation (Fig. 3A) , whereas those of the kP estimates increased by � 7% because of a systematic overestimation (Fig.  3B) from respective values obtained when both the "true" and fixed values of q were 2.3. When the "true" q was 2.8, the r.m.s. error of the Ve esti mates increased by �6% (Fig. 3A) , whereas that of the kP estimates increased by �5%, both because of a systematic overestimation (Fig. 3B) . In both situ ations, the magnitude of the deviation depended on the input values of Ve (0.3-0.9 ml g-I). The lower the input value of Ve, the smaller the deviation of the kP estimates. Figure 3C ,D demonstrates the effects on the Ve and kP estimates of fixing kr to zero in the fitting procedure when the "true" value was nonzero.
When the "true" kr was 0.01 min -I, the r.m.s.
errors of Ve estimates increased by �4% because of a systematic underestimation (Fig. 3C) , while those of kP estimates increased by �8% because of a sys tematic underestimation (Fig. 3D) . The systematic deviation was less prominent when the "true" kf was 0.005 min -I. In both situations, the magnitude of deviation depended on the input values of Ve' The lower the input value of Ve, the smaller the underestimation of the kP estimates.
On the basis of the error analysis, we expect a minimal variation of the kP estimates with a q of 2.3 and a kr of zero for "true" values of q between 1.8 and 2.8, and of kr < 0.01 min -I .
PET studies Choice of the model and values ofk? and kf. In six subjects with HPLC data available up to 90 min following injection of FDOPA, we examined the benefit of including k!j and kf} in the model. We adopted an empirical method because the estimates of k!j and kf} remained uncertain (large COV; data not shown) at 90 min. We plotted the mean normal ized residual sum of squares (RSS) at 90 min (RSS associated with a k!j value divided by the minimum RSS of all k!j values examined) as a function of k!j (Fig. 4A) . The coefficients KP, kP, kf}, and Vo were then estimated. Figure 4 illustrates that a k!j of 0.015-0.02 min -I was associated with a minimal RSS in both putamen and head of caudate nucleus. We found that the RSS associated with zero k!j were significantly greater than those associated with any other k!j examined. Therefore, we con cluded that the loss of metabolites from the brain could not be ignored. When k!j was chosen to be 0.02 min -I, the kf} estimates averaged 0.008 ± 0.002 (min -I) in the putamen and 0.007 ± 0.003 (min -I) in the caudate (Fig. 4B) . The k!jlkf} ratios increased significantly in proportion of the chosen k� values (Fig. 4C) . When k!j was 0.02 min -I, the k!jlkf} ratio averaged 2.8 ± 1.0 in the putamen and 3.8 ± 2.1 in the caudate. We chose 0.02 and 0.005 (min -I) to represent the population means of k� and kf}.
For the two models including (k!j-model) or ex
cluding (kp-model) k� and kf}, Fig. SA shows the time course of the normalized residuals (residuals of each PET frame divided by the RSS) of the putamen and caudate nucleus of all 12 subjects for 60 min. In the k�-model, k� and kf} were fixed to 0.02 and (Fig. 5B) . Normal values. Table 1 summarizes the mean cortical values and standard deviation of the unidi rectional clearance (KP), the decarboxylation coef ficient (kr). and the partition volume ( V e = K/k 2 ). We observed a very large COY of V e (-40%). This was mainly due to intersubject variability (range 0.30-0.84 ml g-I) because the intrasubject variabil ity of V e in cortical structures was less than 5%. The KP of the occipital cortex was significantly higher than for other cortical regions (paired Student's t test, p < 0.05).
The kr values of the striatum and selected struc tures of the limbic system are listed in Table 2 . The kr averaged 0.080-0.082 min -I in the caudate nu cleus and 0.072-0.075 min -I in the putamen. As predicted from the simulated PET studies, the esti mates of kr were lower in the striatum for a floating V e term than for a fixed V e ' When V e was floated as a parameter, the kr estimates were significantly lower than those estimated by the two-step analy sis, and the V e estimates of the striatum exceeded the physiological limit of the relative brain water content (-0.8 ml g-I). In the striatum, the KP es timates of the putamen were significantly higher than those of the caudate nucleus (paired Student's t test, p < 0.05). Figure 6 depicts the radioactivities of individual compartments as predicted by the present analysis for the frontal cortex (left panel) and putamen (right panel) of a healthy subject, together with the mea sured radioactivity. The model predicts that the dif ference between total radioactivities (A *(t)) of the two structures becomes evident 10 min after admin istration of the tracer and increases continuously up assumed "true" values of k5 on the estimates of Ve (C) and k� (0). when k� is fixed to zero in the fitting procedure: The simulation was carried out in the two-step analysis as described above (input values are the same as Fig. 3A ,B except for k�). Systematic deviations of Ve and k� estimates depend on the assumed "true" values of k�. When the assumed "true" k� is 0. 01, r. m.s. errors of V and k� estimates increase by -4 and -8% because of systematic underestimation. The magnitude of the deviations of the k� estimates depend on the input values of Ve' The smaller the input values of Ve' the smaller the deviation of the k� estimates. For the sake of graphical presentation, we chose slightly different input values of k� for different input k� values.
to 60 min. The difference between the metabolic compartments of the two structures accounts for the difference in the total radioactivity.
DISCUSSION
FDOPA model
The biological model underlying the FDOPA PET method (Fig. 1) was constructed on the basis of current physiological and biochemical knowledge of the blood-brain transport into and out of the brain, diffusion within the brain, and the decarbox ylation, O-methylation, and oxidation reactions in the brain of DOPA, FDOPA, and their related me tabolites. The model explains the entire time course of FDOPA uptake into brain when the loss of me tabolites is incorporated into the model (Fig. 5A) . We examined changes of the mean normalized resid ual sum of squares (RSS) in the putamen and caudate nu cleus of six subjects whose HPLC data were available for 90 min (RSS associated with a k� value divided by the minimum RSS of all k� values examined) as a function of fixed k� values (A). The coefficients K�, k�, k�, and Va were estimated. (A) indicates that k� of 0. 015-0.02 min -1 was associated with the minimal RSS on average in both structures. When k� was set to zero, normalized RSS averaged 6. 5 ± 2. 7 in the puta men and 7.3 ± 3.2 in the caudate (data not shown in the figure) . B: The k� estimate vs. fixed k� values: The mean k� decreased and appeared to approach a stable value as fixed k� increased. At k� equal to 0. 02 min -1, the k� estimates were O. OOB ± 0. 002 (min-1) in the putamen and 0. 007 ± 0. 003 (min -1) in the caudate. C: The k�-k� ratio vs. fixed k� values: The ratio increased proportionally to k�. When k� was 0. 02 min -1, the k�-k� ratio averaged 2. B ± 1. 0 in the putamen and 3. B ± 2. 1 in the caudate.
J Cereb Blood Flow Metab, Vol. 13, No.1, 1993 In theory, the decarboxylation coefficient (�) is directly proportional to the maximal velocity of the decarboxylation reaction of FDOPA (V�ax)' i.e., to the amount of enzyme present in a region. For this reason we refer to kr as the relative activity. We obtained a value of 380 nmol g-I h -) for V�ax of human striatum assuming a half-saturation constant (K�) of 100 nmol ml -1 (Cumming et aI., 1988) and a brain water content of O. 78 ml g -) (Lund-Andersen, 1979 ). The value is in good agreement with reported values of V max for human striatum 1183-216 nmol 100 mg protein -1 h -) (Lloyd and Hornykiewicz, 1972) ; 680 nmol g-) h-I (MacKay et aI., 1978) ] when the Km ratio of FDOPA and native DOPA is taken into account [2: 1 (Cumming et aI., 1988) ].
The present kr values for the striatum are twice as large as those reported in our previous commu nication [0.028 min -I for the caudate nucleus and 0.030 min -I for the putamen (Gjedde et aI., 1991)]. There are several possible explanations for this dis agreement. First, the present PET camera has a bet ter axial resolution than the Therascan 3128 scanner (6.4 mm vs. 11.0 mm FWHM). Second, we im proved the anatomical correlation of PET images, using MRI images resliced to the planes of the PET images (Evans et aI., 1991b) . Finally, we changed the method of determining Ve from the original method of determination in planes below the stria tum where kr was assumed to be zero, to the frontal Ve determined by including kr as a parameter. In fact, we found a striata-cortical kr ratio of 7-8: 1 which is in good agreement with the 12-20: 1 value cited by MacKay et aI. (1978) as the mean of pub lished results.
Once decarboxylated, exogenously administered FDOPA may be subject to kinetics completely dif ferent from that of endogeous dopamine (DA). Sev eral hypotheses advocating multiple transmitter pools in dopaminergic terminals (Weiner, 1970; Ja voy and Glowinski, 1971; Westerink and Spaan, 1982; Nissbrandt and Carlsson, 1987) have been proposed. Some reports are consistent with a dif ference between the kinetic behavior of native DOPA and its radioactive tracers (Leviel et aI., 1989) . However, the present model is not invali dated by differences occurring after decarboxyl ation, as long as the metabolites of FDA remain within the tissue of origin. If there is loss of metab olites from the brain, the rate of loss was properly included in the present model.
On the basis of the biochemical literature (Cum ming et aI., 1987; Firnau et aI., 1987; Melega et aI., 1991) • OM 0.07 Tim. (min) FHV A leave the brain as free acids or sulfate con jugates via probenecid-sensitive transport directly into the circulation (Neff et al., 1967; Gordon et al. , 1976; Grabowska-Anden et aI., 1984) or into the cerebrospinal fluid. We believe that the local trans port into the circulation plays a major role in human brain. We assumed that FDA itself and other minor intermediate metabolites such as F3MT do not dif fuse out of the brain (Guldberg et aI., 1971; Wes terink, 1979; Hardebo et aI., 1979) . Assuming first order Michaelis-Menten kinetics for the formation and elimination of FDOPAC and FHVA in the brain, we lumped the two metabolites into a single diffusible metabolite compartment. Huang et ai. (1991) recently published a similar model for FDA metabolism. The authors lumped FDA and its metabolites into one compartment and applied a transfer coefficient for the loss of metab olites from this compartment. According to Fig. 6 , the present method predicts that the rate of loss which is proportional to M�(n increases steadily with time, whereas the model of Huang et ai. (1991) predicts that the rate of loss which is proportional to M�(n + M�(n increases rapidly at an early phase of the study and gradually approaches a steady rate with time.
In this study, it was impossible to explicitly de termine the values of k� and k�. We found a trade off between estimates of kP, k�, and k� when � and k� were floated. However, we observed a local minimum of the residual sum of squares when k� could range only between zero and 0.05 min -1. We adopted 0.02 min -) for k� and 0.005 min -1 for k� as values to be used to estimate the relative L-DOPA decarboxylase activity. These values predicted that M�(t) must be slightly lower than M�(t) at 60 min (Fig. 6) . The prediction agrees very well with the reported time courses of radioactive compounds in the rhesus monkey following injection of FDOPA (Firnau et ai. 1987; Melega et aI., 1991) . The k�-� ratio reflects the ratio of the diffusible compartment to the nondiffusible compartment in a steady state. We obtained a value of 4.0 for this ratio. However, Fig. 4C indicates that the ratio is very sensitive to the assumed value of � and predicts that the injected FDOPA has not reached a steady state at 90 min. One of the cardinal findings of this study was that the two-step method with its constraints yielded kP 0.30 
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FIG. 6. Plot of total and compartmen tal radioactivity contents in typical cortical region (left panel) and puta men (right panel) as functions of cir culation time. The radioactivity con tents are calculated on the basis of the estimates of model parameters and ra dioactivity in plasma using Eqs. A3-A 16 (see Appendix).
estimates with a circulation time of 60 min that were consistent with those based on a circulation time of 90 min (Fig. 5B) . The use of population values for k� and kf did not affect the estimates at 60 min.
Therefore, we can reduce the study time to 60 min without compromising the estimates of k�.
The simulated PET studies played an essential role in identifying the reason for the failure of the least-squares optimization method to yield precise estimates of k� in the absence of the constraints (see above). Using the constraints, the error analy sis indicated the best means to obtain the value of the partition volume (Fig. 2B) , as well as the pos sible consequences for the 1!1 estimates of using a value from the rat of the transport constant in hu man brain (Fig. 3A,B) , and ignoring the O-methyl ation reaction in the brain (Fig. 3C,D) .
Biological constraints
Without the biological constraints, we observed deviations of the k� estimates from the input values in the simulated PET studies ( Fig. 2A) and from the estimates of the constrained method in actual PET studies (Table 2) . It is essential to the analysis of PET data by a compartmental model that the circu lation time extend toward a near-steady-state of the model, as indicated by a linear rise of the slope intercept plot (Gjedde, 1981; Patlak et al., 1983) , or by the half-life of the precursor compartment, In21
(� + k�) (Sokoloff et al., 1977) . However, this does not necessarily guarantee correct estimates because the least-squares optimization method lacks the sensitivity to distinguish between condi tions that reach near-steady-state prior to 60 min (chosen in the simulated study) and those with lower values of the coefficients that require more time to reach near-steady-state. This is the reason for the observed systematic underestimation of k�.
We employed biological constraints to solve the issue of the systematic deviation. The constraints acted as ties between model coefficients that forced the estimates to remain inside the theoretical bounds dictated by physiology and biochemistry. The first constraint was the use of a fixed partition volume to limit the estimates of K) and k2 for both FDOPA and 3-0-methyl-FDOPA (OMFD) (Eq. 5). Unfortunately, this constraint cannot be verified for FDOPA itself because of the decarboxylation.
Equation 5 indicates that the value of the parti tion volume is closely related to the total concen tration of LNAA in plasma, and predicts that amino acids in plasma inhibit LNAA transport across the blood-brain barrier. Leenders et al. (1986b) found that the suppression of FDOPA transport was uni form in the brain regions.
J Cereb Blood Flow Metab, Vol, 13, No, 1, 1993 In theory, the partition volume can be measured most precisely with tracers that cross the blood brain barrier by the LNAA transporter but are not metabolized or trapped in the brain. The partition volume is equal to the distribution volume of those tracers at steady-state. Doudet et al. (1991) demon strated that the partition volume of OMFD is the same in practically all brain regions, including the striatum. Because Koeppe et al. (1990) reported a small intrasubject variability of the partition volume (with a frontal-to-occipital gradient) of [IlC] ami nocyclohexanecarboxylate, we chose the V e value of the frontal cortex for the striatum. Koeppe et al. (1990) also found an intersubject variability of V e of about 15% which is in good agreement with our findings.
The transport ratios between substances compet ing for a facilitated transporter can be regarded as constants (Sokoloff et al., 1977; Gjedde, 1981; Cun ningham and Cremer, 1981; Gjedde and Diemer, 1983; Crane et al., 1983) . Reith et al. (1990) obtained a transport ratio of 2.3 between OMFD and FDOPA in rats. We used this value for the human brain, for which the value is not yet known, for the following two reasons. First, the error analysis indicated that deviation of the chosen value (the value used in the fitting procedure) from the "true" value used to generate the data caused little deviation of the esti mates of V e and � from their respective "true" values. Second, it is safe to assume that the ratio has little intra-and intersubject variability, even when individual values of T max and Kt for FDOPA and OMFD differ among regions and subjects.
In situ O-methylation
Catechol-O-methyItransferase (COMT) is present in the brain with little regional variation (MacKay et al., 1978) . COMT converts FDOPA to OMFD in the brain. At present, the magnitude of the O-methyl ation reaction in the brain is in question. However, the magnitude must be lower than that of the total systemic reaction which combines the O-methyl ation reactions everywhere, including those of the liver and kidneys (V max ratios liver:kidney:brain = 105:40:1; Rivett et al., 1983) . For this reason, we assumed that the brain O-methylation coefficient must be lower than that measured in plasma (0.01 min -); Gjedde et al., 1991) . The error analysis dem onstrated that, for this magnitude of O-methylation, the present analysis is acceptably insensitive to the presence of O-methylation of FDOPA in the brain.
Recently, COMT inhibitors were used in PET studies with L-DOPA tracers. Laihinen et al. (1992) demonstrated that pretreatment with peripherally active OR-462 increased the striatal-cerebellar ra-dioactivity ratio of FDOPA by 20% in humans. Hartvig et al. (1992) In the experiments with FCDOPA, the authors found that pretreatment with peripherally and centrally active RO 40-7529 signif icantly increased the estimates of the "decarboxyl ation rate" (k 3 ) by 60% from 0.0057 ± 0.0006 to 0.0092 ± 0.0015 min -I . A rough estimate of the corresponding changes of the radioactivity ratio (striatum vs. "surrounding brain") was 17% from 1.65 without RO 40-7592 to 1.93 with RO 40-7592 at 90 min of "normalized time," according to their operational equation and assuming that the ratio was 1.15 at 10 min for both conditions. Therefore, the changes of the radioactivity ratio are more likely to be due to contamination from O-methylated tracer derivatives in plasma than to in situ O-meth ylation of the tracers. For CDOPA, the peripheral O-methylation of which is significantly less than that of FDOPA (Hartvig et aI., 1992) , pretreatment with RO 40-7592 did not change the k3 estimates.
We conclude that it is unlikely that in situ O-meth ylation is sufficient to affect the estimates of L-DOPA decarboxylase activity.
Another possibility is the O-methylation of FDOPA in capillary endothelium which may pro vide an important defense against biologically ac tive amines . Accord ing to , the COMT activity in "brain microvessels" (capillaries + venules) is 25 ± 17 pmol mg protein -I h -I, which corresponds to 3.5 and 5% of the respective whole-brain and pial artery activities. If endothelial O-methylation of FDOPA can be expressed by first-order kinetics, the O-methylation coefficient in capillary endothe lium may not exceed 0.00035 min -I (3.5% of 0.01 min -I; see above). The concentration of FDOPA available for the unidirectional transport to intersti tium [C� ' (t)] is then proportional to that in plasma at all times [C� ' (t) = fC�(t), wherefis a constant, consists of five convolution terms and complicated coefficients, it often failed to converge or yielded uncertain estimates (a large COY). An alternative solution is a modification of the linear solution of Blomqvist (1984) . However, there are three major criticisms against this solution; the parameters are overdetermined (i. e., the number of coefficients of the equation exceeds the number of model coeffi cients), the equation contains higher orders of plasma integrals, and it contains, as independent variables, integrals of the brain radioactivity which are subject to greater measurement error in com parison to the plasma radioactivity.
To resolve this complex model configuration, we introduced a new approach to the calculation of the total tissue activity in the fitting procedure, and to the generation of PET data for simulation on the basis of estimates of the model coefficients CKI and ki' i = 2, 3, 5, 7, and 9; a hat denotes estimates of parameters as well as the radioactivity contents of model compartments in the equations below). The new approach makes use of partial solutions of the differential equations of the model (Eqs. 1-4) for each compartment.
The activity of FDOPA in brain at Ij (as distinct from the mid-frame time TJ is given by integration of the differential equation 0):
where C�(t) is the FDOPA concentration in arterial plasma. First, we calculated I1i C�(t)dt by linear integration using all plasma sampling points (see Method for the schedule). Then, the plasma integral was interpolated to every 30 s and used in the follow ing (M = Ij -tj -1 = 30 s). where A *(n is the PET datum observed at time Ti. lt should be noted that the approach requires cal culation of radioactivity contents and their integrals of each compartment; any higher orders of integra tion are unnecessary. The approach is so robust that it converged with Newton's method without direct calculation of the derivatives of individual parameters. This is the advantage of the proposed approach over the operational equation (AI) which includes more demanding convolutions and calcu lation of derivatives.
